FOLH1 and posterior cortical atrophy: In our institute, a Gallium-68 [68Ga] labeled PSMA PET/CT was added to the conventional staging procedure in men with intermediate and high-risk PCa (predominant Gleason pattern 4 or higher, and/or cT3 or higher, and/or PSA blood level ≥ 20) from June 2016 onwards.